MYC and diffuse large B-cell lymphoma: With increasing use and familiarity with MYC IHC, it is our hope to reliably and prospectively identify patients with DLBCL and high MYC protein who may benefit from more aggressive chemotherapy, irrespective of their MYC-translocation status.